(2022) Breast Cancer Survival Statistics [Internet]

Kim SS, Kim SJ, Bae YT, Lee JY, Kim BH, Kim YK et al (2012) Factors associated with the development of new onset diffuse thyroid F18-fluorodeoxyglucose uptake after treatment of breast cancer in patients without a history of thyroid disease or thyroid dysfunction. Thyroid 22(1):53–58. https://doi.org/10.1089/thy.2011.0013

Article  CAS  PubMed  Google Scholar 

Joensuu H, Viikari J (1986) Thyroid function after postoperative radiation therapy in patients with breast cancer. Acta Radiol Oncol 25(3):167–170. https://doi.org/10.3109/02841868609136397

Article  CAS  PubMed  Google Scholar 

Darvish L, Ghorbani M, Teshnizi SH, Roozbeh N, Seif F, Bayatiani MR et al (2018) Evaluation of thyroid gland as an organ at risk after breast cancer radiotherapy: A systematic review and meta-analysis. Clin Transl Oncol 20(11):1430–1438. https://doi.org/10.1007/s12094-018-1875-7

Article  CAS  PubMed  Google Scholar 

Mireștean CC, Iancu RI, Iancu DPT (2021) An underestimated toxicity radiation-induced hypothyroidism in patients multimodally treated for breast cancer. J Clin Med. https://doi.org/10.3390/jcm10235503

Article  PubMed  PubMed Central  Google Scholar 

Wolny-Rokicka E, Tukiendorf A, Wydmański J, Roszkowska D, Staniul BS, Zembroń-Łacny A (2016) Thyroid function after postoperative radiation therapy in patients with breast cancer. Asian Pac J Cancer Prev 17(10):4577–4581. https://doi.org/10.22034/apjcp.2016.17.10.4577

Article  PubMed  PubMed Central  Google Scholar 

Bruning P, Bonfrèr J, De Jong-Bakker M, Nooyen W, Burgers M (1985) Primary hypothyroidism in breast cancer patients with irradiated supraclavicular lymph nodes. Br J Cancer 51(5):659–663. https://doi.org/10.1038/bjc.1985.99

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tunio MA, Al Asiri M, Bayoumi Y, Stanciu LG, Al Johani N, Al Saeed EF (2015) Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study. J Cancer Res Ther 11(4):684–689. https://doi.org/10.4103/0973-1482.167613

Article  CAS  PubMed  Google Scholar 

Kanyilmaz G, Aktan M, Koc M, Demir H, Demir LS (2017) Radiation-induced hypothyroidism in patients with breast cancer: A retrospective analysis of 243 cases. Med Dosim 42(3):190–196. https://doi.org/10.1016/j.meddos.2017.03.003

Article  PubMed  Google Scholar 

Huang H, Roberson J, Hou W, Mani K, Valentine E, Ryu S et al (2021) NTCP model for hypothyroidism after supraclavicular-directed radiation therapy for breast cancer. Radiother Oncol 154:87–92. https://doi.org/10.1016/j.radonc.2020.09.003

Article  PubMed  Google Scholar 

Milano MT, Vargo JA, Yorke ED, Ronckers CM, Kremer LC, Chafe SMJ et al (2021) Primary hypothyroidism in childhood cancer survivors treated with radiation therapy: A PENTEC comprehensive review. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2021.02.001

Article  PubMed  Google Scholar 

Zhao Y, Zhu J, Zhang X, Wu G, Xu Y, Shen P et al (2021) Integrated IMRT vs segmented 3D-CRT of the chest wall and supraclavicular region for breast cancer after modified radical mastectomy: An 8‑year follow-up. J Cancer 12(5):1548–1554. https://doi.org/10.7150/jca.51125

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kivanc H, Gultekin M, Gurkaynak M, Ozyigit G, Yildiz F (2019) Dosimetric comparison of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for left-sided chest wall and lymphatic irradiation. J Appl Clin Med Phys 20(12):36–44. https://doi.org/10.1002/acm2.12757

Article  PubMed  PubMed Central  Google Scholar 

Wang R, Shen J, Yan H, Gao X, Dong T, Li S et al (2022) Dosimetric comparison between intensity-modulated radiotherapy and volumetric-modulated arc therapy in patients of left-sided breast cancer treated with modified radical mastectomy: CONSORT. Medicine 101(2):e28427. https://doi.org/10.1097/MD.0000000000028427

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dogan N, Cuttino L, Lloyd R, Bump EA, Arthur DW (2007) Optimized dose coverage of regional lymph nodes in breast cancer: The role of intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68(4):1238–1250. https://doi.org/10.1016/j.ijrobp.2007.03.059

Article  PubMed  Google Scholar 

Hou PY, Hsieh CH, Wu LJ, Hsu CX, Kuo DY, Lu YF et al (2021) Modern rotational radiation techniques with volumetric modulated arc therapy or helical tomotherapy for optimal sparing of the lung and heart in left-breast cancer radiotherapy plus regional nodal irradiation: A comparative dosimetric analysis. Cancers. https://doi.org/10.3390/cancers13205043

Article  PubMed  PubMed Central  Google Scholar 

Haciislamoglu E, Canyilmaz E, Gedik S, Aynaci O, Serdar L, Yoney A (2019) Effect of dose constraint on the thyroid gland during locoregional intensity-modulated radiotherapy in breast cancer patients. J Appl Clin Med Phys 20(7):135–141. https://doi.org/10.1002/acm2.12668

Article  PubMed  PubMed Central  Google Scholar 

Dumane VA, Bakst R, Green S (2018) Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT. PLoS ONE 13(10):e205770. https://doi.org/10.1371/journal.pone.0205770

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nicolini G, Fogliata A, Clivio A, Vanzetti E, Cozzi L (2011) Planning strategies in volumetric modulated are therapy for breast. Med Phys 38(7):4025–4031. https://doi.org/10.1118/1.3598442

Article  Google Scholar 

Shen G, Peng Y, Li J, Wu H, Zhang G, Zhao C et al (2021) Multivariate NTCP model of hypothyroidism after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Front Oncol 11:714536. https://doi.org/10.3389/fonc.2021.714536

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE, Andersson M et al (2008) Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys 72(4):1021–1030. https://doi.org/10.1016/j.ijrobp.2008.02.040

Article  PubMed  PubMed Central  Google Scholar 

Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56(4):1038–1045. https://doi.org/10.1016/s0360-3016(03)00203-7

Article  PubMed  Google Scholar 

van Barele M, Akdeniz D, Heemskerk-Gerritsen BAM, Andrieu N, Noguès C, van Asperen CJ et al (2023) Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA 1/2 pathogenic variant undergoing radiation. J Natl Cancer Inst 115(11):1318–1328. https://doi.org/10.1093/jnci/djad116

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giannakeas V, Lim DW, Narod SA (2021) The risk of contralateral breast cancer: a SEER-based analysis. Br J Cancer 125(4):601–610. https://doi.org/10.1038/s41416-021-01417-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106. https://doi.org/10.1016/S0140-6736(05)67887-7

Article  CAS  PubMed  Google Scholar 

Boice JD, Harvey EB, Blettner M, Stovall M, Flannery JT (1992) Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326(12):781–785. https://doi.org/10.1056/NEJM199203193261201

Article  PubMed  Google Scholar 

Basco VE, Coldman AJ, Elwood JM, Young ME (1985) Radiation dose and second breast cancer. Br J Cancer 52(3):319–325. https://doi.org/10.1038/bjc.1985.196

Article  CAS  PubMed  PubMed Central  Google Scholar 

Storm HH, Andersson M, Boice JD, Blettner M, Stovall M, Mouridsen HT et al (1992) Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst 84(16):1245–1250.